NORD and C-Path Release Video on Rare Disease Challenges in Each Step of the Drug Development Process
There are over 7,000 rare diseases, approximately 90% do not have FDA-approved treatments, and the process of developing therapies for rare diseases involves special challenges and considerations. NORD and the Critical Path Institute (C-Path) are working together …
Read more